QUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins' clients completed 93 transactions across sectors and regions, highlighting how business leaders are us...
Read article
Finland Finland QUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins' clients completed 93 transactions across sectors and regions, highlighting how business leaders are us...
Read articleQUARTERLY M&A ACTIVITY: In Q2 2025, we facilitated 47 transactions, driving mid-market transactions in TMT, energy and more. Explore trends in cros...
Read articleDEAL FLASH: The Providence Projects, one of the UK’s leading providers of affordable private alcohol and drug rehabilitation services, has been acq...
Read articleQUARTERLY M&A ACTIVITY: In Q1 2025, Oaklins facilitated 59 transactions across a variety of sectors, driving growth amid economic complexities, wit...
Read articleQUARTERLY M&A ACTIVITY: In 2024's Q4, Oaklins completed 90 M&A transactions, with TMT and Healthcare leading, reflecting innovation and strategic g...
Read articleDEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led ...
Read articleQUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry...
Read articleDEAL FLASH: AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to...
Read articleQUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the a...
Read articleQUARTERLY M&A ACTIVITY: Q1 saw a dynamic market with significant M&A activity in various industries, with TMT leading with 15 deals. Energy, Real E...
Read articleQUARTERLY M&A ACTIVITY: Oaklins has proven its adaptability and strategic acumen in a challenging market, completing 87 transactions in Q4 and clim...
Read articleJULY & AUGUST | M&A ACTIVITY: We successfully executed 38 transactions, of which the majority were sell-side. Notably, over 75% of the transactions...
Read articleARTIFICIAL INTELLIGENCE WEBINAR
Read articleDEAL ACTIVITY | MAY: Amidst challenging market conditions, Oaklins sees M&A as a vital corporate strategy to build resilience and outperform compet...
Read articleDEAL FLASH: Oaklins’ team in the Netherlands acted as the exclusive M&A sell-side advisor to the shareholders of DierenDokters. This transaction em...
Read articleFEBRUARY DEAL ACTIVITY: Our activity followed a similar pace to what we saw in the first month of 2023 with 14 transactions closed, of which 13 wer...
Read articleJANUARY DEAL ACTIVITY: As we look to build on our 35+-year track record of helping clients navigate complex market conditions, January 2023 saw us ...
Read articleDEAL FLASH: The acquisition of MBI Healthcare Technologies by DNV AS demonstrates Oaklins’ ability to advise on complex international transactions ...
Read articleExplore our recent deals.
Read articleMONTHLY DEAL ACTIVITY: The ongoing economic turmoil is impacting M&A markets but the appetite for M&A persists with 37 transactions closed in July ...
Read articleDEAL FLASH: The acquisition of Silverlink PCS Software Limited provides Alcidion Group Limited with a PAS capability, which is the foundational dat...
Read articleMONTHLY DEAL ACTIVITY: 2022 has got off to a good start for Oaklins with 36 closed transactions of which 34 were M&A deals and two were fundraising...
Read articleM&A and finding the right source of funding can play a significant role in accelerating recovery. Discover how we have collaborated closely, helpin...
Read articleDEAL FLASH: Ace Pharmaceuticals (Ace) has been acquired by a consortium of Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and Ace’s mana...
Read article